Classical Swine Fever Vaccine, Live

• Varieties: Vaccine
• Component: Virus
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: Tissue Culture Origin
• Pharmacodynamic Influential Factors: Virus
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 154391004
• Usage: Administer Via Intramuscular Injection in The Neck
• Shelf Life: 18 Months
• Temperature: Store at -15ºC
• Withdrawal Period: 0 Day
• Package: 700 Bottles / Carton
• Transport Package: Air Way/Sea Way
• Specification: 10 dose/vial; 20 doses/ vial
• Trademark: SINDER
• Origin: China
• Production Capacity: 100000L/Year
• Package Size: 61.20cm * 34.50cm * 41.00cm
• Package Gross Weight: 20.000kg

Product Description

GENERIC NAME:
Classical Swine Fever Vaccine, Live (Tissue Culture Origin).
COMPOSITION:
This product contains attenuated swine fever virus rabbit adapted strain (CVCC AV1412). Each dose contains a minimum of 750 units of Rabbit Infection Dose.
CHARACTERISTIC:
The product presents as sponge-like loose clumps that easily disengage from the bottle wall, and rapid dissolution in the PBS.
INDICATION(S):
The product is used to prevent the Classic Swine Fever in pigs, cattle and sheep. Immunity is developed 4 days after vaccination. The immunization period for piglets without maternal antibodies after weaning is 12 months.
ADMINISTRATION AND DOSAGE:
Administered through intramuscular or subcutaneous injection. Dilute as per the label, using physiological saline to achieve a concentration of 1 dose per milliliter, with each dose being 1.0 ml.
In regions without a prevalence of swine fever, piglets without maternal antibodies post-weaning can be vaccinated once. In the presence of an epidemic threat, piglets can be vaccinated at approximately 21-30 days and 65 days. Pre-weaning piglets can receive four doses of the vaccine to prevent interference from maternal antibodies, thus ensuring optimal immunization efficacy.
SPECIAL WARNING IF NECESSARY:

1. Transport under refrigeration conditions at or below 8°C.
2. Upon receipt, if the vaccine is stored in cold packaging and the storage environment exceeds 8°C but remains below 25°C, it should be used within 10 days from the reception of the vaccine.
3. Local disinfection should be performed during vaccination.
4. After vaccination, close observation is essential. In case of allergic reactions, prompt injection of adrenaline is recommended.
5. After dilution, if the temperature is below 15°C, use within 6 hours. If the temperature is between 15-27°C, use within 3 hours.
6. Used vaccine bottles, equipment, and any unused vaccines should be disposed of an an environmentally safe manner.

Classical Swine Fever Vaccine, Live (Tissue Culture Origin)
(1) Each dose contains ≥ 15,000 RID
(2) Large-scale production process of bioreactors, the antigen liquid contains more than 1 million RID/ml, and the potency between different batches is stable.
(3) Using real-time PCR detection to ensure no BVDV and other exogenous pathogens.
(4) Low serum culturing and low stress reaction after administration.

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.